TickerFacts.

Quantum Cyber N.V. (QUCY): Revenue

Annual figures by period end, from SEC filings.

$537.1K
Year ended 2025-12-31
$894.0K2024-12-31: $894.0K2025-12-31: $537.1K$537.1K
2024-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$537.1K-39.9%2026-03-31, From 2025-01-01
2024-12-31$894.0Kn/a2026-03-31, From 2024-01-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Quantum Cyber N.V. (QUCY)2025-12-31$537.1K-39.9%
Lipella Pharmaceuticals Inc. (LIPO)2024-12-31$536.4K+19.3%
Silence Therapeutics plc (SLN)2025-12-31$559.0K-98.7%
Yarrow Bioscience, Inc. (YARW)2025-12-31$570.0K+13.8%
Mereo BioPharma Group plc (MREO)2025-12-31$500.0Kn/a
PMGC Holdings Inc. (ELAB)2025-12-31$590.1Kn/a
Vaccinex, Inc. (VCNX)2024-12-31$601.0K+5.4%
BioXcel Therapeutics, Inc. (BTAIQ)2025-12-31$642.0K-71.7%
Polomar Health Services, Inc. (PMHS)2025-12-31$648.2Kn/m

Compare QUCY, LIPO, SLN, YARW side by side · Screen every company in Pharmaceutical Preparations ↗